Elena Maino

Como, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Lichen planopilaris-like eruption in chronic myeloid leukemia patient during treatment with nilotinib as second-line therapy.

Lichen planopilaris-like eruption in chronic myeloid leukemia patient during treatment with nilotinib as second-line therapy.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: January 17, 2022

Eltrombopag as second line treatment in patients with primary immune thrombocytopenia: A single center real life experience.

Eltrombopag as second line treatment in patients with primary immune thrombocytopenia: A single center real life experience.

Journal: Blood cells, molecules & diseases

Published: October 05, 2021

Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature.

Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature.

Journal: Blood cells, molecules & diseases

Published: September 30, 2021

Next-generation sequencing improves BCR-ABL1 mutation detection in Philadelphia chromosome-positive acute lymphoblastic leukaemia.

Next-generation sequencing improves BCR-ABL1 mutation detection in Philadelphia chromosome-positive acute lymphoblastic leukaemia.

Journal: British journal of haematology

Published: October 27, 2020

Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients.

Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients.

Journal: Oncotarget

Published: December 05, 2017

Health-related quality of life in patients with chronic myeloid leukemia receiving first-line therapy with nilotinib.

Health-related quality of life in patients with chronic myeloid leukemia receiving first-line therapy with nilotinib.

Journal: Cancer

Published: October 30, 2017

New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment?

New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment?

Journal: Expert opinion on biological therapy

Published: May 17, 2017

Minimal Residual Disease Assessment and Risk-based Therapy in Acute Lymphoblastic Leukemia.

Minimal Residual Disease Assessment and Risk-based Therapy in Acute Lymphoblastic Leukemia.

Journal: Clinical lymphoma, myeloma & leukemia

Published: January 23, 2017

Burkitt lymphoma in adolescents and young adults: management challenges.

Burkitt lymphoma in adolescents and young adults: management challenges.

Journal: Adolescent health, medicine and therapeutics

Published: January 18, 2017

Immunotherapy approaches to treat adult acute lymphoblastic leukemia.

Immunotherapy approaches to treat adult acute lymphoblastic leukemia.

Journal: Expert review of hematology

Published: March 25, 2016

Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment.

Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment.

Journal: European journal of haematology

Published: December 08, 2015

Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response.

Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response.

Journal: Haematologica

Published: March 31, 2015

Showing 1-12 of 18

Last Updated: 09/26/2026